These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35488921)

  • 21. Exploring various polygenic risk scores for skin cancer in the phenomes of the Michigan genomics initiative and the UK Biobank with a visual catalog: PRSWeb.
    Fritsche LG; Beesley LJ; VandeHaar P; Peng RB; Salvatore M; Zawistowski M; Gagliano Taliun SA; Das S; LeFaive J; Kaleba EO; Klumpner TT; Moser SE; Blanc VM; Brummett CM; Kheterpal S; Abecasis GR; Gruber SB; Mukherjee B
    PLoS Genet; 2019 Jun; 15(6):e1008202. PubMed ID: 31194742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polygenic risk scores for genetic counseling in psychiatry: Lessons learned from other fields of medicine.
    Eeltink E; van der Horst MZ; Zinkstok JR; Aalfs CM; Luykx JJ
    Neurosci Biobehav Rev; 2021 Feb; 121():119-127. PubMed ID: 33301779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polygenic risk scores: from research tools to clinical instruments.
    Lewis CM; Vassos E
    Genome Med; 2020 May; 12(1):44. PubMed ID: 32423490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition.
    Hughes E; Wagner S; Pruss D; Bernhisel R; Probst B; Abkevich V; Simmons T; Hullinger B; Judkins T; Rosenthal E; Roa B; Domchek SM; Eng C; Garber J; Gary M; Klemp J; Mukherjee S; Offit K; Olopade OI; Vijai J; Weitzel JN; Whitworth P; Yehia L; Gordon O; Pederson H; Kurian A; Slavin TP; Gutin A; Lanchbury JS
    JCO Precis Oncol; 2022 Nov; 6():e2200084. PubMed ID: 36331239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
    Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
    Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A principal component approach to improve association testing with polygenic risk scores.
    Coombes BJ; Ploner A; Bergen SE; Biernacka JM
    Genet Epidemiol; 2020 Oct; 44(7):676-686. PubMed ID: 32691445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research review: Polygenic methods and their application to psychiatric traits.
    Wray NR; Lee SH; Mehta D; Vinkhuyzen AA; Dudbridge F; Middeldorp CM
    J Child Psychol Psychiatry; 2014 Oct; 55(10):1068-87. PubMed ID: 25132410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polygenic Risk Score in African populations: progress and challenges.
    Adam Y; Sadeeq S; Kumuthini J; Ajayi O; Wells G; Solomon R; Ogunlana O; Adetiba E; Iweala E; Brors B; Adebiyi E
    F1000Res; 2022; 11():175. PubMed ID: 37273966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.
    Polygenic Risk Score Task Force of the International Common Disease Alliance
    Nat Med; 2021 Nov; 27(11):1876-1884. PubMed ID: 34782789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance.
    Trinder M; Brunham LR
    Curr Opin Lipidol; 2021 Apr; 32(2):103-111. PubMed ID: 33395106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taking the risk. A systematic review of ethical reasons and moral arguments in the clinical use of polygenic risk scores.
    Andreoli L; Peeters H; Van Steen K; Dierickx K
    Am J Med Genet A; 2024 Jul; 194(7):e63584. PubMed ID: 38450933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How do experts in psychiatric genetics view the clinical utility of polygenic risk scores for schizophrenia?
    Moorthy T; Nguyen H; Chen Y; Austin J; Smoller JW; Hercher L; Sabatello M
    Am J Med Genet B Neuropsychiatr Genet; 2023; 192(7-8):161-170. PubMed ID: 37158703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues.
    Lewis ACF; Green RC
    Genome Med; 2021 Jan; 13(1):14. PubMed ID: 33509269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions.
    Fahed AC; Wang M; Homburger JR; Patel AP; Bick AG; Neben CL; Lai C; Brockman D; Philippakis A; Ellinor PT; Cassa CA; Lebo M; Ng K; Lander ES; Zhou AY; Kathiresan S; Khera AV
    Nat Commun; 2020 Aug; 11(1):3635. PubMed ID: 32820175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Communicating polygenic risk scores in the familial breast cancer clinic.
    Das Gupta K; Gregory G; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; McInerney-Leo A; Young MA; James PA; Yanes T
    Patient Educ Couns; 2021 Oct; 104(10):2512-2521. PubMed ID: 33706980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cases in Precision Medicine: The Role of Polygenic Risk Scores in Breast Cancer Risk Assessment.
    Zeinomar N; Chung WK
    Ann Intern Med; 2021 Mar; 174(3):408-412. PubMed ID: 33253037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRS-on-Spark (PRSoS): a novel, efficient and flexible approach for generating polygenic risk scores.
    Chen LM; Yao N; Garg E; Zhu Y; Nguyen TTT; Pokhvisneva I; Hari Dass SA; Unternaehrer E; Gaudreau H; Forest M; McEwen LM; MacIsaac JL; Kobor MS; Greenwood CMT; Silveira PP; Meaney MJ; O'Donnell KJ
    BMC Bioinformatics; 2018 Aug; 19(1):295. PubMed ID: 30089455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On polygenic risk scores for complex traits prediction.
    Zhao B; Zou F
    Biometrics; 2022 Jun; 78(2):499-511. PubMed ID: 33786811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translating polygenic risk scores for clinical use by estimating the confidence bounds of risk prediction.
    Sun J; Wang Y; Folkersen L; Borné Y; Amlien I; Buil A; Orho-Melander M; Børglum AD; Hougaard DM; ; Melander O; Engström G; Werge T; Lage K
    Nat Commun; 2021 Sep; 12(1):5276. PubMed ID: 34489429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
    Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
    Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.